🇺🇸 FDA
Pipeline program

CEFTRIAXONE , CEFIXIME , SULFAMETHOXAZOLE AND TRIMETHOPRIM , AMIKACIN

APHP211043

Phase 3 small_molecule active

Quick answer

CEFTRIAXONE , CEFIXIME , SULFAMETHOXAZOLE AND TRIMETHOPRIM , AMIKACIN for acute pyelonephritis (AP) in children is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
acute pyelonephritis (AP) in children
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials